j365 Index a A[removed]A[removed]

First Page		Document Content
Date: 2011-03-20 22:04:26 Signal transduction Protein kinases Tyrosine kinase Tyrosine-kinase inhibitor Epidermal growth factor receptor C-Raf Aurora inhibitor Platelet-derived growth factor receptor Phosphoinositide 3-kinase Biology Cell biology Chemistry		j365 Index a A[removed]A[removed] Add to Reading List Source URL: www.wiley-vch.de Download Document from Source Website File Size: 62,99 KB Share Document on Facebook

	A Clinical Development CompanyForm 10-K EntreMed, Inc. (Nasdaq: ENMD) is a clinical-stage pharmaceutical company focused on developing DocID: 1aHvd - View Document
	Preliminary Programme Cell Cycle Regulators/Inhibitors and Cancer February 5-8, 2011, Vienna Austria Saturday, February – 18.00 DocID: 17yuA - View Document
	Product Name: Additive T Category: Aluminum Brightening Order Code: ADDT METAL FINISHING PRODUCTS Source: Aurora, NC Alternate Names: Transfer Etch Inhibitor DocID: 13toZ - View Document
	Encouraging Data on Astex’s Anti-Cancer Drug AT9283 to be Presented at ASH New Data Suggest a Potential Role for AT9283 in Combination With Lenalidomide and With Docetaxel in the Treatment of Multiple Myeloma and Non-H DocID: 11oTO - View Document
	Astex Pharmaceuticals to Present at AACR Annual Meeting DUBLIN, Calif., March 29, [removed]Astex Pharmaceuticals, Inc. (NASDAQ: ASTX), a pharmaceutical company dedicated to the discovery and development of novel small mole DocID: 11m6h - View Document